Correlation Between ADMA Biologics and VBI Vaccines
Can any of the company-specific risk be diversified away by investing in both ADMA Biologics and VBI Vaccines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ADMA Biologics and VBI Vaccines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ADMA Biologics and VBI Vaccines, you can compare the effects of market volatilities on ADMA Biologics and VBI Vaccines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ADMA Biologics with a short position of VBI Vaccines. Check out your portfolio center. Please also check ongoing floating volatility patterns of ADMA Biologics and VBI Vaccines.
Diversification Opportunities for ADMA Biologics and VBI Vaccines
-0.61 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between ADMA and VBI is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding ADMA Biologics and VBI Vaccines in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VBI Vaccines and ADMA Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ADMA Biologics are associated (or correlated) with VBI Vaccines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VBI Vaccines has no effect on the direction of ADMA Biologics i.e., ADMA Biologics and VBI Vaccines go up and down completely randomly.
Pair Corralation between ADMA Biologics and VBI Vaccines
Given the investment horizon of 90 days ADMA Biologics is expected to generate 0.29 times more return on investment than VBI Vaccines. However, ADMA Biologics is 3.43 times less risky than VBI Vaccines. It trades about 0.13 of its potential returns per unit of risk. VBI Vaccines is currently generating about -0.09 per unit of risk. If you would invest 351.00 in ADMA Biologics on August 31, 2024 and sell it today you would earn a total of 1,832 from holding ADMA Biologics or generate 521.94% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 83.65% |
| Values | Daily Returns |
ADMA Biologics vs. VBI Vaccines
Performance |
| Timeline |
| ADMA Biologics |
| VBI Vaccines |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
ADMA Biologics and VBI Vaccines Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ADMA Biologics and VBI Vaccines
The main advantage of trading using opposite ADMA Biologics and VBI Vaccines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ADMA Biologics position performs unexpectedly, VBI Vaccines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VBI Vaccines will offset losses from the drop in VBI Vaccines' long position.| ADMA Biologics vs. Atara Biotherapeutics | ADMA Biologics vs. Fate Therapeutics | ADMA Biologics vs. Sana Biotechnology | ADMA Biologics vs. Caribou Biosciences |
| VBI Vaccines vs. Tonix Pharmaceuticals Holding | VBI Vaccines vs. Jaguar Animal Health | VBI Vaccines vs. Vaxart Inc | VBI Vaccines vs. Allogene Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |